Trastuzumab deruxtecan belongs to a group of antineoplastic drugs known as antibody-drug conjugates (ADCs). This type of ...

Scientists have discovered that a promising new anticancer medicine currently in development could be made from unknown ...

Professor Park Joong-won of the Department of Gastroenterology at Myongji Hospital announced that the combination treatment ...

This came after AstraZeneca Pharma India presented the proposal for a grant of permission to import and market Osimertinib ...

The Inflation Reduction Act, passed by Congress and signed into law by President Joe Biden in 2022, legislated new policies ...

New Delhi: Pfizer has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control ...

The global generic oncology drugs market size is estimated to grow from USD 24,389 million in 2025 and is projected to be ...

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

The most expensive drug category for nonfederal hospitals in 2024 were antineoplastic targeted agents, according to a study published in the American Journal of Health-System Pharmacy.  The report, ...